The independent source for health policy research, polling, and news.
29,501 - 29,520 of 112,460 Results
The vaccine would stop opioids by effectively blocking them from reaching the brain by way of the circulatory system. It is one suggestion in a renewed push to treat addiction like a disease rather than a lack of willpower or character flaw.
The FDA says that the products “present a significant public health threat" and that it will immediately begin removing them from the market.
Marc-David Munk, a proponent of in-clinic diagnostics and treatment, will become CVS’s chief medical officer for its MinuteClinics.
The House Appropriations Committee passed the new version of the budget that includes a handful of amendments to woo Senate Republicans. The lawmakers in the upper chamber had blocked the budget earlier because of the House's attempts to expand the state's Medicaid program. Medicaid news comes out of Colorado, Tennessee, Mississippi, Florida and Maine, as well.
The tactic of suing companies over potentially harmful products is a lucrative one, and those looking to get a chunk of that money have made a business out of luring women into sometimes unnecessary procedures to make them a more valuable plaintiff.
Some in the movement see the possible retirement of Justice Anthony Kennedy as their chance to have the Supreme Court revisit Roe v. Wade. Other activists want to focus on more incremental gains instead, though.
Generic drug developers need samples of brand-name drugs to show that a generic copy is equivalent to the original, but the drug companies are refusing to provide samples of their products. In other pharmaceutical news: an appeals court hands the industry a victory in price gouging case; a former Mallinckrodt employee claims she was fired for warning company about illegal sales practices; and a shortage of EpiPens outside the U.S.
After years of using the health law as a rallying cry with voters, Republican candidates are keeping quiet on the topic. “Yeah, we probably can’t talk credibly about repeal and replace anymore,” said Rep. Tom MacArthur (R-N.J.).
Today's early morning highlights from the major news organizations.
Editorial pages focus on these and other health topics.
Each week, KHN compiles a selection of recently released health policy studies and briefs.
Media outlets report on news from Michigan, Georgia, Ohio, New Jersey, Connecticut, Pennsylvania, Kentucky, Massachusetts, Texas and D.C.
House Del. Alfonso Lopez said there could be a bill as early as Monday or Tuesday of next week. Medicaid news comes out of Pennsylvania and Mississippi, as well.
Former employee Cecilia Guardiola said she discovered that Banner hospitals billed an "inordinate and improper number of short-stay claims, particularly those for expensive cardiac procedures," according to the Justice Department statement.
It's the first screening device the FDA has authorized that doesn't need a clinician's interpretation to look for a particular condition. In other news, the agency also is going to relax its review of next-generation sequencing tests.
Launched in 2013, the project has recruited more than 300 children ages 3-12 from 45 states, with the goal of tracking their development over 20 years. In other public health news: melanoma, brain damage, bathroom hand dryers, ovarian cancer, air pollution, "cool caps," and more.
Nearly 60 percent of the 38,658 gun deaths in the U.S. in 2016 were people taking their own lives, and advocates say "red flag" laws, which allow officials to seize weapons from people who may be a threat to themselves or others, can play a role in combating that trend.
While heavier drinkers were less likely to have a heart attack, the increased risk of a stroke and other heart problems outweighed that benefit.
While Minnesota Department of Human Services wants to close its books on the matter, some Republicans in the GOP-controlled Legislature are pushing legislation that could force DHS to collect payments it's owed by July 1.
An analysis finds that the new medications, which could carry a $8,500 price tag, are not cost effective. In other pharmaceutical news, a gene therapy trial for Duchenne muscular dystrophy has begun, and an online pharmacy is fined for importing counterfeit cancer drugs.
© 2026 KFF